Dentovskaya S V, Ivanov S A, Kopylov P Kh, Shaikhutdinova R Z, Platonov M E, Kombarova T I, Gapel'chenkova T V, Balakhonov S V, Anisimov A P
State Research Center for Applied Microbiology, Obolensk, Moscow Region, 142279, Russia.
Irkutsk Antiplague Research Institute of Siberia and Far East, Trilissera Str., 78, 664047, Irkutsk, Russia.
Acta Naturae. 2015 Jan-Mar;7(1):102-8.
It has recently been shown that the NlpD lipoprotein is essential to Yersinia pestis virulence and that subcutaneous administration of the nlpD mutant could protect mice against bubonic and pneumonic plague better than the EV vaccine strain [PLoS One 2009. V. 4. № 9. e7023]. In this study, similar ΔnlpD mutants were generated on the basis of other Y. pestis parent strains, including strains from the subspecies microtus, which is avirulent to guinea pigs and humans. Comparative testing confirmed that immunization of mice with ΔnlpD mutants induces immunity 105 times more potent than the one induced by the administration of the EV vaccine strain. At the same time, NlpD- bacteria failed to protect guinea pigs in the case of a subcutaneous challenge with Y. pestis, inducing a 106 times less potent protection compared with that conferred by immunization with the EV vaccine strain. The possible causes of the observed phenomena are discussed.
最近研究表明,NlpD脂蛋白对鼠疫耶尔森菌的毒力至关重要,皮下注射nlpD突变体比EV疫苗株能更好地保护小鼠免受腺鼠疫和肺鼠疫的侵害[《公共科学图书馆·综合》2009年。第4卷。第9期。e7023]。在本研究中,基于其他鼠疫耶尔森菌亲本菌株,包括对豚鼠和人类无毒的田鼠亚种菌株,构建了类似的ΔnlpD突变体。对比试验证实,用ΔnlpD突变体免疫小鼠诱导的免疫力比注射EV疫苗株诱导的免疫力强105倍。同时,在皮下接种鼠疫耶尔森菌的情况下,NlpD缺陷型细菌未能保护豚鼠,与用EV疫苗株免疫相比,其诱导的保护效力低106倍。文中讨论了观察到这些现象的可能原因。